More research on Nrf2 and its extensive therapeutic application as an add-on to the standard treatment of SLE should be performed, as it might be a promising approach to enhance antioxidant expression, decrease ROS production, and suppress inflammatory response. The gene discussed is NFE2L2; the disease is systemic lupus erythematosus.